Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Establishment and Characterization of 10 Human Pancreatic Cancer Cell Lines Including a HER2 Overexpressed Cell Line.

Pancreas - 1 Jan 2000

Kim Soon-Chan, Shin Young-Kyoung, Kim Sun-Whe, Seo Ha-Young, Kwon Wooil, Kim Hongbeom, Han Youngmin, Lee Ja-Oh, Jang Jin-Young, Ku Ja-Lok

Abstract excerpt

OBJECTIVE: The incidence of pancreatic adenocarcinoma (PA) approximates its prevalence, as the malignancy is almost consistently fatal within a year. Although the currently available adjuvant therapy seems to provide survival benefit, it is only moderate, and the standard regimen has not yet been established. Therefore, more biological resources to investigate the PA are needed. METHODS: Here, we established and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line, Tumor
Share to Adenocarcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Exome Sequencing

Share to Gene Amplification

Share to Mutation

Share to Pancreatic Neoplasms

Share to Receptor, ErbB-2

Source

Open in PubMed Open full text

Identifiers

PMID: 31688591
DOI: 10.1097/MPA.0000000000001420
PMCID: PMC6867661

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Establishment and Characterization of 10 Human Pancreatic Cancer Cell Lines Including a HER2 Overexpressed Cell Line.PMID 31688591Read ↗

Pancreatic acinar cell carcinoma: A review on molecular profiling of patient tumors.Semantic proximity Read ↗

Cellular and molecular aspects of pancreatic cancer.Semantic proximity Read ↗

Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset.Semantic proximity Read ↗

An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression.Semantic proximity Read ↗

Pancreatic cancer genomics.Semantic proximity Read ↗

Integrated Patient-Derived Models Delineate Individualized Therapeutic Vulnerabilities of Pancreatic CancerSemantic proximity Read ↗

Molecular and Phenotypic Profiling for Precision Medicine in Pancreatic Cancer: Current Advances and Future PerspectivesSemantic proximity Read ↗

Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable MutationsSemantic proximity Read ↗

A Holistic View of the Biology of Pancreatic Cancer and Targeted Therapeutic Approaches to Treat the CancerSemantic proximity Read ↗

Pancreatic adenocarcinomas without KRAS, TP53, CDKN2A and SMAD4 mutations and CDKN2A/CDKN2B copy number alterations: a review of the genomic landscape to unveil therapeutic avenues.Semantic proximity Read ↗

Clinical and molecular characterization of HER2amplified-pancreatic cancerSemantic proximity Read ↗

Pancreatic ductal adenocarcinomas from Mexican patients present a distinct genomic mutational pattern.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.